Study S001946

A Multi-center, Randomized, Open-label, Active-controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin-naive Type 2 Diabetic Patients Inadequately Controlled With Metformin and Sulphonylurea Combination Therapy.

ClinicalTrials.gov record

Registration

Registration: NCT01051011
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: TERMINATED
Enrollment: 370
Start: 2010-01
Primary completion: 2010-12
Lead sponsor: Hoffmann-La Roche
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG:insulin glargine; DRUG:metformin; DRUG:taspoglutide
Results posted: FALSE

Registered primary outcomes

Glycemic control assessed by HbA1c [week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.